GlobeNewswire by notified

eureKARE launches innovation-driven start-up studio in Monaco to apply synthetic biology in tackling critical environmental challenges

Share

To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

eureKARE launchesinnovation-drivenstart-up studio in Monacotoapplysynthetic biology in tacklingcriticalenvironmental challenges

Luxembourg, Belgium, and Paris, France – 15November2022: eureKARE ("the Company"), an innovative investment company for disruptive synthetic biology applications, today announces the launch of an innovation-driven start-up studio in Monaco, focused on supporting and housing synthetic biology projects which aim to tackle the world’s most pressing environmental challenges. This expands eureKARE’s synthetic biology studio network – each with a different theme – in Europe’s innovation hotspots. The Monaco studio will be the network’s hub for climate change-focused innovation.

eureKARE’s synthetic biology studio model is a novel, flexible approach to biotech start-up creation which identifies, selects and nurtures high quality European science to create a unique ecosystem, putting resources and expertise behind scientists and concepts to create and develop new companies.

Alexandre Mouradian, Chairman, Founder, and Chief Executive Officer of eureKARE, commented:By promoting synthetic biology-based strategies, we will see the emergence of novel sustainable solutions and new economic models that will prove invaluable in addressing some of the world’s largest environmental challenges. The excellence of the marine research being conducted in Monaco was a key determinantin selecting Monaco as one of ourSynBio start-up hubs. Together with eureKARE’s support and insight, I am excited to see where this will take us.”

The Monaco studio will focus on nurturing projects dedicated to better protect and more sustainably harness environmental resources. Plastic pollution is an example of a critical environmental concern with around 400 million tons of plastic waste occurring every year. Engineering novel micro-organisms to digest plastic pollutants and to synthesize sustainable plastics is one of the projects expected to be supported by eureKARE’s Monaco studio. Another project under evaluation is the use of synthetic biology to enable certain marine organisms to sense the presence of pollutants in sea water and trigger a bioremediation (decontamination) reaction.

Serge Pampfer, Chief Science Officer of eureKARE, added:Among the most exciting SynBio start-up projects that are being considered for investment by eureKARE in Monaco, those aimed at developing cutting-edgetechnologies to better harness and protect our marine resources are going to take center stage. This is due to the growing need to better protect our oceans, coupled with the wide array of disruptive applications SynBiocan have in this area.

- Ends-

About eureKARE

eureKARE is an investment company focused on financing and developing synthetic biology innovation across Europe. Driven by the belief that synthetic biology holds the key to many of the world’s most pressing health and environmental challenges, eureKARE’s experienced team is focused on harnessing Europe’s untapped leadership in the field to build the companies of the future. eureKARE is championing a new model of start-up creation and development to create a dynamic ecosystem of early and later stage ventures through its network of biotech studios. eureKARE’s studios act as a bridge between academia and industry, helping to catalyze innovations into companies with access to all the ingredients they need to grow, prosper, and bring benefits to society.

Contacts

eureKARE SA
Cátia Dourado, Communications Manager
catia.dourado@eurekare.eu

Consilium Strategic Communications – Media Relations
Amber Fennell, Sukaina Virji, Genevieve Wilson
eurekare@consilium-comms.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Press Release: Statement from Sanofi regarding: rule 2.12 of the takeover rules2.12.2022 07:55:00 CET | Press release

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.12 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 (THE "TAKEOVER RULES"). NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. DECEMBER 2, 2022 Statement from Sanofi regarding: rule 2.12 of the takeover rules Paris, December 2, 2022. As required by Rule 2.12 of the Takeover Rules, Sanofi S.A. (“Sanofi”) confirms that any offer for Horizon Therapeutics plc, if made by Sanofi, will be solely in cash. There is no certainty that any offer will be made, nor as to the terms on which any such offer may be made, if forthcoming. About Sanofi We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible

Sampo plc’s share buybacks 01/12/20222.12.2022 07:30:00 CET | Press release

SAMPO PLC STOCK EXCHANGE RELEASE 02/12/2022 at 08:30 am Sampo plc’s share buybacks 01/12/2022 On 01/12/2022 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows: Sampo plc’s share buybacksAggregated daily volume (in number of shares)Daily weighted average price of the purchased shares*Market (MIC Code)14,22948.68AQEU31,99648.68CEUX13,98448.68TQEX59,79148.64XHELTOTAL120,00048.66 *rounded to two decimals On 9 June 2022, Sampo announced a share buyback programme of up to a maximum of EUR 1 billion in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 10 June 2022, is based on the authorization granted by Sampo's Annual General Meeting on 18 May 2022. After the disclosed transactions, the company owns in total 16,801,839 Sampo A shares representing 3.15 per cent of the total number of shares in Sampo plc. Details of

AB Linas Agro Group investors calendar for the 20232.12.2022 07:30:00 CET | Press release

A list of key information disclosure dates in 2023: February 28, 2023Interim half-year unaudited report for FY 2022/2023.March 1, 2023Investor Conference Webinar to introduce unaudited financial and activity results for the half-year of FY 2022/2023.May 31, 2023Interim unaudited report for 9 months of FY 2022/2023.June 1, 2023Investor Conference Webinar to introduce unaudited financial and activity results for 9 months of FY 2022/2023.August 31, 2023Interim unaudited report for 12 months of FY 2022/2023.September 4, 2023Investor Conference Webinar to introduce unaudited financial and activity results for 12 months of FY 2022/2023.Week 40 (Oct 2-6, 2023)Notice on Annual General Meeting of shareholders.Week 43 (Oct 23-27, 2023)Resolutions of the Annual General Meeting of shareholders and Annual audited results for FY 2022/2023.November 30, 2023Interim unaudited report for 3 months of 2023/2024 financial year.December 1, 2023Investor Conference Webinar to introduce unaudited financial and

Arcadis completes the acquisition of DPS Group, creating a leading position in the Life Sciences and Semiconductor manufacturing market2.12.2022 07:00:00 CET | Press release

Arcadis completes the acquisition of DPS Group, creating a leading position in the Life Sciences and Semiconductor manufacturing market Creates a full-service advisory for high-tech industrial manufacturing clients, combining DPS Group’s (DPS) and Arcadis’ complementary service offeringsDPS’s high growth and resilient Life Sciences and Semiconductor manufacturing expertise will become part of Arcadis’ Places Global Business Area (GBA)Arcadis adds an extra 2,850 talented employees to its growing business, increasing headcount by over 20% to 36,000 since the beginning of 2022Arcadis’ Simon Bimpson to lead Arcadis DPS Group, and current DPS’ Chief Executive, Frank Keogh to take on the role of strategic advisor Amsterdam, 2 December 2022 – Arcadis, the leading global design & consultancy organization for natural and built assets has today announced it has completed the acquisition of DPS, a leading consultancy, engineering and construction management company for Life Sciences and Semicondu

Mandalay Resources Corporation Announces Refinancing of Credit Facility2.12.2022 02:26:55 CET | Press release

Not for distribution to U.S. news wire services or dissemination in the United States. TORONTO, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation (“Mandalay” or the “Company”) (TSX: MND, OTCQB: MNDJF) is pleased to announce that it has entered into a credit agreement with The Bank of Nova Scotia (“Scotiabank”) providing for a senior secured revolving credit facility in an aggregate amount of up to US$35 million (the “Revolving Credit Facility”). The initial drawdown under the Revolving Credit Facility will be used to repay the Company’s existing syndicated facility with HSBC Bank Canada and Macquarie Bank Limited (the “Existing Facility”) which had US$32.6 million outstanding before repayment. The residual proceeds from the Revolving Credit Facility will be used for general corporate and working capital purposes. The hedge arrangements entered into in connection with the Existing Facility will remain in place until their expiry in June 2023. The Revolving Credit Facility